LR Health & Beauty SE announced the completion of its financial realignment process, which included strengthening its capital base and sustainably reducing its debt level. The company received an initial financial tranche of approximately $11.3 million at the end of March and will receive a second tranche at the end of June.
This new financing structure is expected to improve financial flexibility, enable further investments into infrastructure and facilitate continued international growth. Key priorities for future investments now include the Ahlen production site, where it plans to strengthen capacity and efficiency; continued development and optimization of logistics processes to enhance delivery performance and service quality; and targeted investments to support expansion into new international markets.
The company described the realignment as “opening a new chapter” that is “built on a solid financial foundation, clear growth ambitions and a consistent focus on the needs of its partners and customers.”
“The past months have been challenging for many parties involved,” said Jörg Körfer, LR Health & Beauty SE CEO. “We are therefore particularly pleased to have successfully completed the company’s financial realignment. We would like to express our sincere gratitude to our sales partners, suppliers, employees and investors who have accompanied and supported us throughout this period. With our newly established financing structure, we now have a substantially stronger foundation for the future. Our focus is now fully directed towards further strengthening our operational capabilities, driving growth and sustainably enhancing collaboration with our partners.”
